life-sciences - Yahoo! News Search Results
As deal making in the life sciences industry sought to rebound in 2011, the Life Sciences Practice of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. played an integral role in a number of notable transactions, representing life sciences industry clients in more than 60 deals with an aggregate value of over $3 billion.
On February 7, 2012, H&Q Life Sciences Investors declared a stock distribution of $0.26 per share. The record date for the stock distribution is February 22, 2012 and the payable date is March 30, 2012.
SAN DIEGO, Feb. 7, 2012 /PRNewswire/ -- BIOCOM, the trade organization representing Southern California's life sciences industry, has released its first regional economic impact report showing conclusively ...
MILFORD, Mass., Feb. 7, 2012 /PRNewswire/ -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS - News), a global life sciences company providing vital products and services to facilitate the discovery, development and ...
With a $5 million grant that was awarded yesterday by the Massachusetts Life Sciences Center , the Museum of Science, Boston can begin construction of a timely new exhibit, the Hall of Human Life , starting this summer.
NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, increased 21% during 2011, according to ...
Jubilant Life Sciences reported a net loss of Rs 78.3 crore for the quarter ended December 2011. The company had earned a profit of Rs 44 crore during the corresponding period last year. Consolidated revenues climbed 26 per cent to Rs 1,087 crore from Rs 866 crore.
NEW YORK and PHILADELPHIA, Jan. 31, 2012 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS) the world's first drug development company based on open innovation, announced its official launch today with ...
With its concentration of pharmaceutical giants and academic powerhouses, the region could be a major center for life sciences businesses, developers say.
ATLANTA -- OTC Stock Review announces that it has initiated coverage of Anavex Life Sciences Corp. . AVXL is utilizing its proprietary SIGMACEPTOR(TM) Discovery Platform to discover and develop new drugs ...
